Glipizide
Brand name: Glipizide
Rank #264 of 500 drugs by total cost
$46.9M
Total Cost
2,961,035
Total Claims
$46.9M
Total Cost
80,655
Prescribers
$16
Cost per Claim
564,206
Beneficiaries
7,065,415
30-Day Fills
$581
Avg Cost/Provider
37
Avg Claims/Provider
About Glipizide
Glipizide (sold as Glipizide) was prescribed 2,961,035 times by 80,655 Medicare Part D providers in 2023, costing the program $46.9M. At $16 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 261 | Cenobamate (Xcopri) | $47.6M | 33,831 |
| 262 | Clozapine (Clozapine) | $47.0M | 491,951 |
| 263 | Pembrolizumab (Keytruda) | $46.9M | 3,947 |
| 264 | Glipizide (Glipizide) | $46.9M | 2,961,035 |
| 265 | Losartan/Hydrochlorothiazide (Losartan-Hydrochlorothiazide) | $46.3M | 2,039,676 |
| 266 | Darunavir (Prezista) | $46.0M | 21,793 |
| 267 | C1 Esterase Inhibitor (Haegarda) | $45.8M | 894 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology